I hear you, but one of , if not the, biggest impediment to our sales is the legacy of years of demonization of the drug due to side effects from its use for general anaesthesia decades ago.
It's a bit like the fight over the last 10 years trying to get cannabis back on the medicinal market.
The more people's attitude to its use for any purpose changes, the more momentum there is for take-up for other applications.
That's how I see it anyway.
Green Whistle UK, page-194
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $40.99M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3446 | 47.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 49.0¢ | 193 | 1 |
View Market Depth
| Last trade - 09.34am 12/07/2024 (20 minute delay) ? |
| MVP (ASX) Chart |
Day chart unavailable